CAH Newborn Screening in India: Challenges and Opportunities
Congenital adrenal hyperplasia (CAH) is a common treatable disorder which is associated with life-threatening adrenal crisis, sexual ambiguity, and/or abnormal growth if undiagnosed. Newborn screening is a cost-effective tool to detect affected babies early after birth to optimize their treatment an...
Saved in:
Main Authors: | Aashima Dabas (Author), Meenakshi Bothra (Author), Seema Kapoor (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn Screening for CAH-Challenges and Opportunities
by: Natasha L. Heather, et al.
Published: (2021) -
Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
by: Atsumi Tsuji-Hosokawa, et al.
Published: (2021) -
Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
by: Mark R de Hora, et al.
Published: (2020) -
Newborn Screening by Genomic Sequencing: Opportunities and Challenges
by: David Bick, et al.
Published: (2022) -
Charting the Course: Towards a Comprehensive Newborn Screening Program in India
by: Seema Kapoor, et al.
Published: (2024)